Australian Super Pty LTD Baxter International Inc Transaction History

Australian Super Pty LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	BUY	$63.83 - $80.0 $42.4 Million - $53.2 Million	664,396 Added 182.45%	1,028,551 $66.1 Million
Q1 2022 Apr 29, 2022	SELL	$76.85 - $89.45 $1.27 Million - $1.48 Million	-16,526 Reduced 4.34%	364,155 $28.2 Million
Q4 2021 Jan 24, 2022	BUY	$74.57 - $87.19 $2.62 Million - $3.06 Million	35,126 Added 10.17%	380,681 $33.5 Million
Q3 2021 Nov 12, 2021	BUY	$73.77 - $83.61 $5.96 Million - $6.75 Million	80,739 Added 30.49%	345,555 $27.8 Million
Q2 2021 Aug 12, 2021	BUY	$80.5 - $88.01 $6.67 Million - $7.29 Million	82,843 Added 45.52%	264,816 $21.3 Million
Q1 2021 May 14, 2021	SELL	$76.38 - $86.03 $318,428 - $358,659	-4,169 Reduced 2.24%	181,973 $15.3 Million
Q4 2020 Feb 11, 2021	BUY	$75.39 - $82.36 $14 Million - $15.3 Million	186,142 New	186,142 $14.9 Million
Q4 2017 Jan 18, 2018	SELL	$61.45 - $66.05 $9.67 Million - $10.4 Million	-157,300 Closed	0 $0
Q3 2017 Dec 15, 2017	BUY	$59.5 - $64.61 $9.36 Million - $10.2 Million	157,300	157,300 $9.87 Million

949

457M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $15.4B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Australian Super Pty LTD, based on Form 13F filings with the SEC.

Stay updated on Australian Super Pty LTD with notifications on news.